| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.0046 | 1 |